Paracervical Block in Laparoscopic Hysterectomy

• Status: Unknown status
• Trial end date: 2021-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

It remains controversial whether paracervical block should be performed as a powerful strategy for pain relief in total laparoscopic hysterectomy (TLH), because convincing conclusions are difficult to draw because of the heterogeneous and contradictory nature of the literature. Therefore, the aim of this study was to evaluate the efficacy of paracervical blocks using with 0.5% bupivacaine prior to TLHs for benign gynecologic conditions on postoperative pain relief.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Kangbuk Samsung Hospital
• Treatments: Bupivacaine

Criteria

Inclusion Criteria:

• age between 18 and 65 years

• American Society of Anesthesiologists physical status (ASAPS) classification I-II

• the absence of pregnancy at the time of surgery

Exclusion Criteria:

• history of cervical surgery such as conization or cerclage

• inability to perform the paracervical block due to anatomical abnormalities (i.e., very atrophic or small cervix)

• allergy to bupivacaine, planned concomitant surgical procedures involving extensive additional tissue manipulation such as pelvic lymph node dissection

• any concomitant surgery of pelvic floor repair (uterosacral ligament suspension or sacrocolpopexy) or vaginal procedures (anterior or posterior colporrhaphy or mid-urethral slings), previously taking opioids for chronic pain

• inability to accurately express their pain